New Data on Benefit, Risk for Anticoagulation in COVID-19
New observational studies home in on benefits and risks of anticoagulation in COVID-19 patients, suggest which regimens may be more effective, and show unsuspected emboli at autopsy in many.
New observational studies home in on benefits and risks of anticoagulation in COVID-19 patients, suggest which regimens may be more effective, and show unsuspected emboli at autopsy in many.
“FTC chief warns of healthcare price fixing risks driven by technology advancements, emphasizing the use of algorithms and the agency’s focus on protecting cons
Senator Bernie Sanders is pressing the drugmaker Novo Nordisk for details on its pricing of the popular diabetes and weight loss medications.
The American Hospital Association has urged the Federal Trade Commission to withdraw its proposed move to ban noncompete agreements.
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
This Consensus Report is intended to provide clinical professionals with evidence-based guidance about individualizing nutrition therapy for adults with di
GLP-1 drugs are an important tool to manage diabetes or obesity. But more resources could be spent on prevention to avoid having to treat the…
SIT Shibaura Institute of Technology (Tokyo)
AbstractContext. Metabolic surgery remains the most effective and durable treatment for severe obesity and related metabolic diseases.Objective. We examine
The measure, which would require ByteDance to sell the popular app or stop operating in the U.S., now heads to the Senate.
Objective Maternal obesity affects 39.7% of reproductive-age women in the United States. Emerging research has suggested that in utero exposure to maternal obesity is associated…